ReviewCureus2025
Early Detection of Diabetic Cardiomyopathy Using Speckle Tracking Echocardiography: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Is Insulin Pump Therapy More Effective Than Multiple Daily Insulin Injections in Preventing Subclinical Cardiac Dysfunction in Children With Type 1 Diabetes Mellitus? A Myocardial Strain Study by Three-Dimensional Speckle-Tracking Echocardiography.Echocardiography (Mount Kisco, N.Y.) · 2026Article
- Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics.Diabetes/metabolism research and reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic cardiomyopathy (DCM) represents a distinct myocardial disease that develops independently of coronary artery disease and hypertension in patients with diabetes mellitus. Early detection of subclinical myocardial dysfunction is crucial for timely intervention and improved patient outcomes, as traditional echocardiographic parameters often remain normal during the initial disease stages. Speckle tracking echocardiography (STE) has emerged as a sensitive, non-invasive imaging technique capable of detecting subtle myocardial deformation abnormalities before conventional parameters become abnormal. This systematic review evaluated the effectiveness of STE in early detection of DCM by analyzing original research studies that assessed myocardial strain parameters in patients with diabetes with preserved left ventricular ejection fraction. A comprehensive literature search was conducted across multiple databases from inception to June 2025, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Seven studies met the inclusion criteria, encompassing 361 diabetic patients and 300 healthy controls, with publication years ranging from 2013 to 2022. The review included both type 1 and type 2 diabetes mellitus patients with varying disease durations and glycemic control levels. Global longitudinal strain emerged as the most consistently impaired parameter across all studies, demonstrating a significant reduction in patients with diabetes compared to controls despite preserved ejection fraction. Additional strain parameters, including circumferential, radial, and area strains, showed progressive impairment correlating with diabetes duration and glycemic control. Three-dimensional speckle tracking provided enhanced assessment capabilities, revealing more comprehensive myocardial dysfunction patterns. Multi-layered strain analysis demonstrated preferential endocardial involvement, supporting the pathophysiological understanding of subendocardial fiber vulnerability in the hearts of patients with diabetes. Right ventricular strain assessment revealed biventricular involvement in DCM. The findings consistently demonstrated correlations between strain abnormalities and diabetic microvascular complications, suggesting systemic disease involvement. This review provides compelling evidence supporting STE as a valuable tool for early DCM detection, enabling potential early intervention strategies to prevent progression to symptomatic heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.